Attending the "International Symposium on Tick Borne
Pathogens and Disease ITPD 2026"?
https://www.itpd-tickborne.com/2026/programme.php
Come and meet Iva Trifonova from Iva Cristova's team, our partner and WP leader in #CCHFVACIM project
https://www.cchfvacim.eu/
🚀 #CCHFVACIM is advancing an mRNA vaccine against CCHF toward Phase II trials — building on CCHFVaccine results.
Progress relies on sustained BSL-3/4 access and strong European collaboration.
🔗 Read more: https://cchfvacim.pulse.ly/w0zkvexwgw
🦠 A little-known virus. A very real risk for Europe
Crimean-Congo Haemorrhagic Fever (CCHF) is a deadly tick-borne disease (up to 40% fatality) with no licensed vaccine
🔗 Read on CORDIS:cordis.europa.eu/article/id/463154-preven...
#CCHFVACIM
Great news from the #CCHFVACIM project!
Colleagues just published a new rapid pseudotyped neutralisation assay for high-risk bunyaviruses, including CCHFV.
Fast, adaptable, safe — and a major boost for vaccine development & Disease X preparedness.
https://www.nature.com/articles/s41541-025-01278-8
As Europe warms, #Hyalomma ticks carrying #CCHFV expand northward.
parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-...
The #CCHFVACIM project unites partners across Europe to boost vaccine development & preparedness.
#OneHealth #ERINHA
🧬 New publication out!
Research from FLI, led by Kerstin Fischer, provide the 1st evidence of the immunogenicity of NSDV GP38 in sheep.
These insights are key for improving serological tools and understanding NSDV as a model for CCHFV
🔗 doi.org/10.1128/jvi....
💶 Funded by the EU #CCHFVacim project
#CCHFVACIM, an EU-funded project coordinated by #FOHM with ERINHA as a partner (www.cchfvacim.eu), is building a biobank from Crimean-Congo Haemorrhagic Fever (CCHF) survivors.
Curious how survivor antibodies help shape vaccines?
Read more: cepi.net/how-disease-...